These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7314093)

  • 1. Effects of inducer of liver drug-metabolizing enzyme on blood level of active metabolites of cyclophosphamide in rats and in cancer patients.
    Maezawa S; Ohira S; Sakuma M; Matsuoka S; Wakui A; Saito T
    Tohoku J Exp Med; 1981 May; 134(1):45-53. PubMed ID: 7314093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coenzyme Q10 in cancer chemotherapy--experimental studies on augmentation of the effects of masked compounds, especially in the combined chemotherapy with immunopotentiators].
    Kokawa T; Shiota K; Oda K; Okubo S; Okamoto Y; Okubo H
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):768-74. PubMed ID: 6881995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased antitumor activity of cyclophosphamide (Endoxan) following pretreatment with inducer of drug-metabolizing enzymes (cytochrome P-450).
    Oira S; Maezawa S; Irinoda Y; Watanabe K; Kitada K
    Tohoku J Exp Med; 1974 Sep; 114(1):55-60. PubMed ID: 4432244
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined cancer chemotherapy with cyclophoshamide and an inducer of microsomal drug-metabolizing enzymes (cytochrome P-450) in tumor-bearing rats.
    Oira S; Maezawa S; Irinoda Y; Watanabe K; Kitada K
    Tohoku J Exp Med; 1975 Aug; 116(4):341-50. PubMed ID: 1188917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo studies on the transformation of cyclophosphamide to mutagenic metabolites].
    Della Morte R; Belisario MA; Farina C; Martire G; Staiano N; De Lorenzo F
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1061-7. PubMed ID: 7138675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
    Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
    J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenobarbital and beta-naphthoflavone on the activation of cyclophosphamide to mutagenic metabolites in vitro by liver and kidney from male and female rats.
    Hales BF; Jain R
    Biochem Pharmacol; 1980 Jul; 29(14):2031-7. PubMed ID: 6996685
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of cytochrome P-450 forms in liver microsomes of rats in the early neonatal period after administration of phenobarbital and 3-methylcholanthrene].
    Guliaeva LF; Mishin VM; Liakhovich VV
    Biokhimiia; 1985 Nov; 50(11):1817-24. PubMed ID: 4063404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated rats.
    Struck RF; Kari P; Kalin J; Montgomery JA; Marinello AJ; Love J; Bansal SK; Gurtoo HL
    Biochem Biophys Res Commun; 1984 Apr; 120(2):390-6. PubMed ID: 6732764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.
    Fujisaki H; Mise M; Ishii Y; Yamada H; Oguri K
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1024-31. PubMed ID: 7906730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hepatic drug-metabolizing enzymes induced by 3-methylcholanthrene and phenobarbital between pre- and postnatal rats.
    Sunouchi M; Takanaka A; Mizokami K; Inoue K; Fujimori K; Kasuya Y; Omori Y
    Toxicol Appl Pharmacol; 1984 May; 73(3):457-63. PubMed ID: 6326348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
    Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation.
    Clarke L; Waxman DJ
    Cancer Res; 1989 May; 49(9):2344-50. PubMed ID: 2706622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of phenobarbital on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
    Papac DI; Franklin MR
    Drug Metab Dispos; 1988; 16(2):259-64. PubMed ID: 2898344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of phenobarbital on rat liver microsomal drug-metabolizing enzymes and heme-metabolizing enzyme.
    Kurata N; Yoshida T; Kuroiwa Y; Masuko T; Hashimoto Y
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):161-79. PubMed ID: 2587838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver.
    Ong T; Mukhtar M; Wolf CR; Zeiger E
    J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of phenobarbital and its hydroxylated metabolites on drug-metabolizing enzymes during ontogenesis.
    Cresteil T; Mahu JL; Beaune P; Columelli S; Leroux JP
    Pediatr Pharmacol (New York); 1981; 1(4):331-40. PubMed ID: 6810295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.